Furthermore,
a Cbl-b-MyD88 regulatory axis is not required for TLR inhibition in macrophages. Instead, Itgb2−/- macrophages presented with enhanced IκBα degradation, leading to changes in NF-κB recruitment to target promoters and elevated cytokine, chemokine, and anti-apoptotic gene transcription. Thus, β2 integrins limit TLR signaling by inhibiting NF-κB pathway activation and promoting p38 MAPK activation, thereby fine-tuning TLR-induced inflammatory responses. Innate immune cell activation depends on the activity of Toll-like receptors (TLRs) that bind conserved molecular features expressed on invading pathogens [1]. Upon encountering microbes, macrophages and dendritic cells (DCs) respond to TLR stimulation by inducing antimicrobial and antiviral programs that result in the rapid synthesis and secretion selleck compound of inflammatory cytokines and type I interferons. In turn, this potent response must be restrained to spare host tissues from the deleterious effects of exaggerated inflammation. This is accomplished by a variety of inhibitory mechanisms, including cytoplasmic effectors that block TLR signaling directly as well as secreted negative regulators, which work together to limit the severity of the immune response [2]. Although originally considered as an archetypal cell activation pathway, signals through immunoreceptor tyrosine-based
activation motifs (ITAMs) display functional heterogeneity and have been PLX4032 cost recently appreciated to cross-inhibit TLR responses [3, 4]. ITAM signaling in myeloid cells is mediated by the ITAM-containing molecules DAP12 and FcRγ, which act as signaling adapters for an extensive collection of cell surface receptors [5-7]. Following ligand binding by paired receptors, ITAM signaling via DAP12 and FcRγ in myeloid cells proximally activates
Src-family kinases and Syk kinase to enable downstream signals that are predominantly associated with cellular activation, including inducing NF-κB and MAPK pathways, and prompting the release of intracellular Rutecarpine Ca2+ stores [5]. However, depending on the identity of the associated receptor and other undefined parameters, ITAM-based signaling can also induce inhibitory responses. For example, triggering of the DAP12-coupled TREM-2 receptor can dampen TLR activation in macrophages [8]. In addition, TREM-2 and/or DAP12-deficient macrophages and DCs produce more inflammatory cytokines in response to TLR stimulation [9-12], demonstrating that these adapter molecules can transduce signals attenuating TLR activation. During an inflammatory response, leukocytes in the blood adhere to the activated vascular endothelium through the use of integrins. In particular, members of the β2 integrin family facilitate leukocyte firm adhesion, thereby allowing for cell extravasation into the tissues [13].